Siro Clinpharm Private Limited, a active private limited company, was established on 21 March 2000 in Mumbai, Maharashtra, India. Engaging in drug formulation & development within the professional, scientific and technical sector, it holds CIN: U24230MH2000PTC125061. Registered under ROC Roc Mumbai. it is unlisted. It has an authorized capital of ₹25.00 Cr and a paid-up capital of ₹0.61 M.
It upholds a compliant status. Employing 258 professional, Its leadership includes Akshay Gautam Daftary (Director), Karan Gautam Daftary (Whole-Time Director), Gautam Vinod Daftary (Director). Past directors included Anil Ahuja Satya, Sanjay Chandrasen Rane, Akshay Gautam Daftary. It holds ₹5.16 Cr open charges and ₹119.93 Cr settled loans. Its latest AGM occurred on 31 December 2024, with the balance sheet filed on 31 March 2024. It is based at 16Th Floor, Hoechst House, Nariman Point, Mumbai, Mumbai City Mh 400021, Mumbai, Maharashtra, 400021.
U24230MH2000PTC125061
125061
21 March 2000
₹25.00 Cr
₹0.61 M
Roc Mumbai
Unlisted
Active
Explore comprehensive insights into Siro Clinpharm Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Akshay Gautam Daftary | Director | 12 Feb 2018 | Current |
| Karan Gautam Daftary | Whole-Time Director | 12 Sep 2018 | Current |
| Gautam Vinod Daftary | Director | 21 Mar 2000 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Alternate Director | 19 Dec 2011 | Past |
| Pramod Abcsdd | Company Secretary | 31 Jan 2019 | Past |
| Pramod Abcsdd | Additional Director | 30 Jul 2022 | Past |
| Pramod Abcsdd | Nominee Director | 07 Jan 2013 | Past |
| Pramod Abcsdd | Key Managerial Personnel | - | Past |
| Pramod Abcsdd | Nominee Director | 25 Mar 2014 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Siro Clinpharm Private Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 24.91% increase. The company also saw a substantial improvement in profitability, with a 559.59% increase in profit. The company's net worth Soared by an impressive increase of 76.45%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2023, Siro Clinpharm had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
₹51,585,000.00
₹1,199,320,000.00
| Date | Lender | Amount | Status |
|---|---|---|---|
| 30 Dec 2024 | Others | ₹1.50 Cr | Open |
| 16 Oct 2024 | Others | ₹1.29 Cr | Open |
| 27 Mar 2024 | Others | ₹1.37 Cr | Open |
| 24 Nov 2021 | Others | ₹1.00 Cr | Open |
| 12 Mar 2019 | Others | ₹4.50 Cr | Satisfied |
Explore comprehensive loan charge details -
Siro Clinpharm has a workforce of 258 employees as of Mar 22, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Gain comprehensive insights into the Deals and Valuation data of Siro Clinpharm, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Siro Clinpharm's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Siro Clinpharm Private Limited last Annual general meeting of members was held on 31 Dec 2024 as per latest MCA records. was recorded as a recent event.
The activity A charge with Others amounted to Rs. 1.50 Cr with Charge ID 101035220 was registered on 30 Dec 2024. was completed.
The activity A charge with Others amounted to Rs. 1.29 Cr with Charge ID 100995543 was registered on 16 Oct 2024. was completed.
Siro Clinpharm Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Mumbai. was recorded as a recent event.
The activity A charge with Others amounted to Rs. 1.37 Cr with Charge ID 100910202 was registered on 27 Mar 2024. was completed.
A charge with Others amounted to Rs. 1.00 Cr with Charge ID 100517853 was registered on 24 Nov 2021. was recorded as a recent event.
When you're the best at clinical trials and need a partner to help you grow, who you gonna call? Pitchfork Partners! They'll use their strategic communication skills to help you achieve your goals. And with the rise in clinical trial approvals, there's no stopping you. Siro Clinpharm and Pitchfork Partners, a match made in pharma heaven..
The CIN of Siro Clinpharm Private Limited is U24230MH2000PTC125061.
Siro Clinpharm Private Limited is headquartered at 16Th Floor, Hoechst House, Nariman Point, Mumbai, Mumbai City Mh 400021, Mumbai, Maharashtra, 400021.
Siro Clinpharm Private Limited was incorporated on 21 March 2000.
The current directors of Siro Clinpharm Private Limited are
The primary industry of Siro Clinpharm Private Limited is Professional, Scientific And Technical.
Siro Clinpharm Private Limited is unlisted.
The authorized capital of Siro Clinpharm Private Limited is ₹25.00 Cr, and the paid-up capital is ₹0.61 M.
The compliance status of Siro Clinpharm Private Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX